Stromal Cells News Today

Traditional autism treatment methods use a mixture of cognitive behavioral therapy, counseling and medication to try to encourage the patient's brain to

  GÖTTINGEN, Germany, January 05, 2023 / B3C newswire / -- The life science group Sartorius extended a strategic collaboration partnership agreement with RoosterBio Inc. (RoosterBio) to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. Th...

The next exciting step in regenerative therapies has Dr. Thomas Koch, Ontario Veterinary College, and his team encapsulating stem cells to see if they can enhance the effect of treatment. Horses with osteoarthritis in their joints stand to benefit from a therapy with a slower release time.

“When you encapsulate the cells within hydrogel, you can keep the cells in the joint longer, and this may lead to better treatment outcomes.”

Four researchers at UCL have been awarded prestigious EU funding for the next five years for projects in sustainable food, computer science, human rights and liver disease.

 E-Mail IMAGE: Research team from Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam. view more  Credit: AlphaMed Press Durham, NC -- Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today in STEM CELLS Translational Medicine. In a randomized clinical trial at Vinmec Research Institute of Stem Cell an...

1* 1Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, United States 2Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, United States 3Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, United States 4Department of Pathology, Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL, United States Tumo...

Published: Apr 21, 2021 - Backed by leading healthcare investors including SV Health Investors - Cambridge, UK, 20 April 2021 – Mestag Therapeutics (“Mestag”), a breakthrough inflammatory disease and immuno-oncology company, today announced its launch with $11 million seed financing from healthcare investors SV Health Investors and Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”). The Company’s mission is to develop new medicines for patients by targeting activated fibroblas...